Sign in

CIK 0001326110

  • Large accelerated filer

ImmunityBio, Inc.

Sign in to watch
Ticker
IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
431979754
Phone
+1 844-696-5235
Business address
3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
Former names
NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
  1. 4 Open-market sale See remarks sold 75,000 shares at $7.56 ($567,338)
  2. 4 Open-market sale See remarks sold 36,932 shares at $5.52 ($203,698)
  3. 4 Open-market sale See remarks sold 28,068 shares at $5.50 ($154,509)
  4. 4 Shares withheld for taxes Chief Financial Officer gave up 6,132 shares (to pay taxes)
  5. 4 Open-market sale Director sold 30,000 shares at an average $2.87 ($86,000)
  6. 4 Open-market sale Director sold 10,000 shares at $1.99 ($19,918)
  7. 4 Open-market sale Director sold 24,000 shares at an average $1.24 ($29,790)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 3,458 shares (to pay taxes)
  9. 4 Grant or award Director acquired 92,592 shares (grant or award)
  10. 4 Grant or award Director acquired 92,592 shares (grant or award)
  11. 4 Grant or award Director acquired 92,592 shares (grant or award)
  12. 4 Grant or award Director acquired 300,925 shares (grant or award)
  13. 4 Grant or award Director acquired 92,592 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Other acquisition Chairman and CEO acquired 17,589,250 shares (code O)
  16. 4 Open-market sale Director sold 138,349 shares at $1.65 ($228,276)
  17. 4 Open-market sale Director sold 151,159 shares at an average $1.74 ($263,110)
  18. 4 Open-market sale Director sold 32,212 shares at an average $2.02 ($64,934)
  19. 4 Open-market sale Director sold 196,280 shares at an average $2.29 ($450,068)
  20. 4 Derivatives Options or other derivatives

Page 9 of 13 · 251 filings